Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
   
 
Prescribed Drug Estimates: 2002

Table 1.2 Top Prescribed Drugs by Total Purchases, 2002

Prescribed
drug name
Total purchases
ranking
Total
purchases
Total number of
persons with purchases

Lipitor
1
66,679,037

11,301,794

Synthroid
2
51,718,909

7,841,287

Hydrochlorothiazide
3
48,249,795

8,888,302

Atenolol
4
47,530,033

7,512,284

Toprol
5
42,768,491

6,842,729

Premarin
6
42,708,571

7,521,245

Zocor
7
37,090,399

6,941,974

Norvasc
8
35,010,211

5,539,168

Albuterol
9
34,441,006

11,193,700

Furosemide
10
32,813,154

5,314,018


Standard Errors for Table 1.2: Top Prescribed Drugs by Total Purchases, 2002

Prescribed
drug name
Total
purchases
Total number of
persons with purchases

Lipitor
3,312,697.63
473,718.40
Synthroid
2,560,508.03
326,805.86
Hydrochlorothiazide
2,209,447.45
362,998.63
Atenolol
2,488,794.79
348,170.02
Toprol
2,223,485.69
314,400.17
Premarin
2,442,387.28
359,732.62
Zocor
2,245,321.71
350,714.64
Norvasc
2,138,036.26
298,045.51
Albuterol
1,571,673.58
402,345.10
Furosemide
2,245,218.97
291,479.54

 


MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov